Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

This grant funds research units that will develop and test new molecular and imaging biomarkers for early detection of pancreatic ductal adenocarcinoma and its precursor lesions. It supports multidisciplinary studies on fluid-based biomarkers, imaging of pancreatic cysts, screening high-risk populations, and machine-learning approaches for biomarker discovery and validation.

Amount: up to $600,000
Type: Grant

Key facts

Key facts for Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
Amount	up to $600,000
Issuer	National Institutes of Health
Who can apply	Small businesses, companies, universities and 7 more
Sectors	HealthTech
Deadline	Closes 05 Nov 2029

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked just now

10 days agoagentImported from the official source

Opportunities with the same funding type or region
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)		Closes 20 Jun 2029
Human-Environment and Geographical Sciences Program (HEGS)		Closes 15 Jan 2027
National Digital Newspaper Program	up to $325,000	Closes 13 Jan 2027